RRC ID 56150
Author Tsuji-Tamura K, Ogawa M.
Title Dual inhibition of mTORC1 and mTORC2 perturbs cytoskeletal organization and impairs endothelial cell elongation.
Journal Biochem Biophys Res Commun
Abstract Elongation of endothelial cells is an important process in vascular formation and is expected to be a therapeutic target for inhibiting tumor angiogenesis. We have previously demonstrated that inhibition of mTORC1 and mTORC2 impaired endothelial cell elongation, although the mechanism has not been well defined. In this study, we analyzed the effects of the mTORC1-specific inhibitor everolimus and the mTORC1/mTORC2 dual inhibitor KU0063794 on the cytoskeletal organization and morphology of endothelial cell lines. While both inhibitors equally inhibited cell proliferation, KU0063794 specifically caused abnormal accumulation of F-actin and disordered distribution of microtubules, thereby markedly impairing endothelial cell elongation and tube formation. The effects of KU0063794 were phenocopied by paclitaxel treatment, suggesting that KU0063794 might impair endothelial cell morphology through over-stabilization of microtubules. Although mTORC1 is a key signaling molecule in cell proliferation and has been considered a target for preventing angiogenesis, mTORC1 inhibitors have not been sufficient to suppress angiogenesis. Our results suggest that mTORC1/mTORC2 dual inhibition is more effective for anti-angiogenic therapy, as it impairs not only endothelial cell proliferation, but also endothelial cell elongation.
Volume 497(1)
Pages 326-331
Published 2018-2-26
DOI 10.1016/j.bbrc.2018.02.080
PII S0006-291X(18)30303-6
PMID 29428724
MeSH Angiogenesis Inhibitors / administration & dosage Animals Cell Line Cell Size Cytoskeleton / physiology* Cytoskeleton / ultrastructure* Endothelial Cells / cytology* Endothelial Cells / physiology* Everolimus / administration & dosage Mechanistic Target of Rapamycin Complex 1 / antagonists & inhibitors* Mechanistic Target of Rapamycin Complex 1 / metabolism Mechanistic Target of Rapamycin Complex 2 / antagonists & inhibitors* Mechanistic Target of Rapamycin Complex 2 / metabolism Mice Morpholines / administration & dosage Pyrimidines / administration & dosage
IF 2.705
Times Cited 8
Human and Animal Cells UV♀2(RCB1994)